BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer’s Disease

  If approved, aducanumab would become the first therapy to reduce the clinical decline of Alzheimer’s disease andto meaningfully change the course of Alzheimer’s disease

  October 30, 2020

   · 

  9 min read
• Drug Development

  Cerevel Therapeutics Announces First Patients Dosed in all Phase 3 Trials of Tavapadon for the Treatment of Parkinson’s Disease

  Company developing investigational treatment for both newly diagnosed patients and those with a more advanced form of the disease in need of adjunctive therapy

  October 30, 2020

   · 

  6 min read
• Business

  Imperative Care Appoints Chief Operating Officer Daniel Davis as President and Member of Board of Directors

  Imperative Care, Inc., a company singularly dedicated to addressing unsolved problems in stroke, today announced that its Chief Operating Officer, Daniel Davis, has been appointed as the company’s President.

  October 30, 2020

   · 

  3 min read
• Business

  Tikcro Technologies Reports Second Quarter 2020 Results

  Tikcro Technologies Ltd. (OTCQB: TIKRF) today reported its financial results for the second quarter ended June 30, 2020.

  October 30, 2020

   · 

  2 min read
• Drug Development

  BioLineRx Announces Positive Results from Interim Analysis of GENESIS Phase 3 Trial of Motixafortide (BL-8040) in Stem Cell Mobilization

  Enrollment to cease immediately; topline data anticipated in H1 2021

  October 30, 2020

   · 

  6 min read
• ICON plc to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference

  ICON plc, a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, announced that Mr. Brendan Brennan, CFO of ICON plc

  October 30, 2020

   · 

  2 min read
• Genmab and ADC Therapeutics Announce Amended Agreement for Camidanlumab Tesirine (Cami)

  Genmab A/S (Nasdaq: GMAB) and ADC Therapeutics SA (NYSE: ADCT) today announced that they have executed an amended agreement for ADC Therapeutics to continue the development and commercialization of camidanlumab tesirine (Cami).

  October 30, 2020

   · 

  11 min read
• Job Trends

  Superior HealthPlan Urges Breast Cancer Screenings after Delays Due to COVID-19

  As healthcare facilities across Texas resume scheduling routine appointments and screenings, Superior HealthPlan is reminding communities of the importance of preventive healthcare.

  October 30, 2020

   · 

  3 min read
• Business

  HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Tuesday, November 10

  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the third quarter ended September 30, 2020 after the market close on Tuesday, November 10, 2020

  October 30, 2020

   · 

  1 min read
• Business

  AbbVie Reports Third-Quarter 2020 Financial Results

  AbbVie (NYSE: ABBV) announced financial results for the third quarter ended September 30, 2020.

  October 30, 2020

   · 

  28 min read